Related references
Note: Only part of the references are listed.Adverse effects of voriconazole:: Analysis of the French pharmacovigilance database
Celine Eiden et al.
ANNALS OF PHARMACOTHERAPY (2007)
Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients:: A prospective, multicenter, observational study
N Singh et al.
TRANSPLANTATION (2006)
Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial
BJ Kullberg et al.
LANCET (2005)
Voriconazole-induced musical hallucinations
AK Agrawal et al.
INFECTION (2004)
Development and validation of a high-performance liquid chromatography assay for voriconazole
GJ Pennick et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis
R Herbrecht et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.
TJ Walsh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis
DW Denning et al.
CLINICAL INFECTIOUS DISEASES (2002)
A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients
R Ally et al.
CLINICAL INFECTIOUS DISEASES (2001)
Share Paper
